Altimmune CEO Durso buys 30,700 common shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Altimmune, Inc. (ALT) President and CEO Jerome Benedict Durso purchased 30,700 shares of common stock on November 13, 2026, at $1.6187 per share. His directly held position after the purchase was 93,200 shares. No Rule 10b5-1 plan is reported for the purchase.
Insider Trade Summary
Net Buyer: 30,700 shares
Net Buy
1 txn
Insider
Durso Jerome Benedict
Role
President and CEO
Bought
30,700 shs ($50K)
Increase in Position
49.1%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock, par value $0.0001 | 30,700 | $1.6187 | $50K |
Holdings After Transaction:
Common Stock, par value $0.0001 — 93,200 shares (Direct)
Holdings Before and After:
Common Stock, par value $0.0001, 62,500 to 93,200 shares (Direct)
Other Insiders: 2 other insiders reported open-market purchases of this stock in the 30 days up to this filing.
Key Figures
Shares purchased: 30,700 shares
Purchase price: $1.6187 per share
Direct holdings after purchase: 93,200 shares
3 metrics
Shares purchased
30,700 shares
November 13, 2026; common stock
Purchase price
$1.6187 per share
November 13, 2026
Direct holdings after purchase
93,200 shares
After the November 13, 2026 purchase
Key Terms
Rule 10b5-1 plan
1 terms
Rule 10b5-1 plan financial
"No Rule 10b5-1 plan is reported for the purchase."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.